No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New Promissory Note

Listed on SEDAR, $350,000CAN for 150,000 warrants exercise price $.75

Share
New Message
Please login to post a reply